Cas:5318-76-3 1,3-bis[3-(4,5-dihydro-1H-imidazol-2-yl)phenyl]urea,dihydrochloride manufacturer & supplier

Chemical Name:1,3-bis[3-(4,5-dihydro-1H-imidazol-2-yl)phenyl]urea,dihydrochloride

CAS.NO:5318-76-3

Synonyms:Imidocarb HCl;EINECS 226-179-7;Imidocarb dihydrochloride;4A65;Imidocarb hydrochloride;Imizocarb;Diamidine (babesicide)

Molecular Formula:C₁₉H₂₂Cl₂N₆O

Molecular Weight:421.32400

HS Code:

Physical and Chemical Properties:

Melting point:350° (dec)

Boiling point:528.1ºC at 760mmHg

Density:N/A

Index of Refraction:

PSA:89.91000

Exact Mass:420.12300

LogP:3.30900

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like Imidocarb HCl chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Diamidine (babesicide) physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Imidocarb hydrochloride Use and application,Imizocarb technical grade,usp/ep/jp grade.

Related News: Pre-approval Access Programs (also known as expanded access, early access, compassionate use, named patient supply) are regulatory-compliant processes permitting experimental agents in development to be made available upon the request of a physician or a patient for appropriate patients for whom no alternative treatment option exists in their country. 1,3-bis[3-(4,5-dihydro-1H-imidazol-2-yl)phenyl]urea,dihydrochloride manufacturer In the context of increasingly tight global productive capacity cooperation in the pharmaceutical industry, some multinational pharmaceutical companies have chosen to abandon their original full industrial chain model and shift their focus to market operations. R & D, clinical, and production links reduce costs through outsourcing. Patented APIs came into being. 1,3-bis[3-(4,5-dihydro-1H-imidazol-2-yl)phenyl]urea,dihydrochloride supplier Defense Secretary Mark Esper has approved a request to provide military housing for up to 1,000 people who may need to be quarantined after arriving in the US from overseas travel, the Pentagon said in a statement. 1,3-bis[3-(4,5-dihydro-1H-imidazol-2-yl)phenyl]urea,dihydrochloride vendor The injection has previously proven to be as effective as standard daily pills with three active ingredients when administered monthly and also once every two months. 1,3-bis[3-(4,5-dihydro-1H-imidazol-2-yl)phenyl]urea,dihydrochloride factory Pre-approval Access Programs (also known as expanded access, early access, compassionate use, named patient supply) are regulatory-compliant processes permitting experimental agents in development to be made available upon the request of a physician or a patient for appropriate patients for whom no alternative treatment option exists in their country.